Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
DELISTED
Strata Skin Sciences
SSKN
| $1.53M | ﹤0.01% |
133,088
+11,403
| +9% | +$135K |
2016 Q1
17 quarters
|
|
2327
Lisata Therapeutics
LSTA
$11.5M
| $1.53M | ﹤0.01% |
57,266
+28,801
| +101% | +$847K |
2016 Q2
16 quarters
|
|
2328
DELISTED
Clearside Biomedical
CLSD
| $1.53M | ﹤0.01% |
54,096
+27,903
| +107% | +$822K |
2019 Q4
2 quarters
|
|
2329
Weyco Group
WEYS
$491M
| $1.52M | ﹤0.01% |
70,628
-11,672
| -14% | -$227K |
2014 Q2
24 quarters
|
|
2330
SandRidge Energy
SD
$513M
| $1.52M | ﹤0.01% |
1,180,419
-120,581
| -9% | -$181K |
2017 Q4
10 quarters
|
|
|
QEP
2331
DELISTED
QEP RESOURCES, INC.
QEP
| $1.52M | ﹤0.01% |
1,179,599
-5,342,882
| -82% | -$4.98M |
2019 Q4
2 quarters
|
|
2332
Grupo Cibest SA
CIB
$22.4B
| $1.52M | ﹤0.01% |
57,800
-366,400
| -86% | -$9.6M |
2016 Q1
17 quarters
|
|
2333
Tvardi Therapeutics
TVRD
$13.7M
| $1.52M | ﹤0.01% |
+2,468
| New | +$1.36M |
2020 Q2
0 quarters
|
|
|
AAIC
2334
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.52M | ﹤0.01% |
510,481
-242,975
| -32% | -$650K |
2018 Q3
7 quarters
|
|
|
BSQR
2335
DELISTED
BSQUARE Corporation
BSQR
| $1.51M | ﹤0.01% |
951,302
+22,779
| +2% | +$29.2K |
2013 Q2
28 quarters
|
|
2336
Valhi
VHI
$402M
| $1.51M | ﹤0.01% |
143,951
+15,664
| +12% | +$167K |
2014 Q2
24 quarters
|
|
2337
Radcom
RDCM
$172M
| $1.51M | ﹤0.01% |
185,033
+16,100
| +10% | +$116K |
2013 Q2
28 quarters
|
|
|
RNET
2338
DELISTED
RigNet, Inc.
RNET
| $1.5M | ﹤0.01% |
697,400
+166,400
| +31% | +$236K |
2013 Q2
28 quarters
|
|
2339
Cadiz
CDZI
$290M
| $1.5M | ﹤0.01% |
+147,434
| New | +$1.65M |
2020 Q2
0 quarters
|
|
2340
Ponce Financial Group
PDLB
$485M
| $1.5M | ﹤0.01% |
205,221
-6,696
| -3% | -$43.9K |
2018 Q3
7 quarters
|
|
|
PVG
2341
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.5M | ﹤0.01% |
179,100
-875,100
| -83% | -$7.13M |
2019 Q2
4 quarters
|
|
2342
Helios Technologies
HLIO
$2.29B
| $1.5M | ﹤0.01% |
40,175
-12,625
| -24% | -$430K |
2013 Q2
28 quarters
|
|
2343
Carpenter Technology
CRS
$19.1B
| $1.5M | ﹤0.01% |
61,600
-81,700
| -57% | -$1.81M |
2020 Q1
1 quarter
|
|
2344
DELISTED
United Security Bancshares
UBFO
| $1.49M | ﹤0.01% |
222,358
-40,200
| -15% | -$252K |
2013 Q2
28 quarters
|
|
2345
Liberty Latin America Class A
LILA
$1.59B
| $1.49M | ﹤0.01% |
238,806
-252,645
| -51% | -$1.66M |
2019 Q1
5 quarters
|
|
2346
StoneX
SNEX
$7.39B
| $1.49M | ﹤0.01% |
136,824
-179,719
| -57% | -$1.56M |
2018 Q3
7 quarters
|
|
2347
RBB Bancorp
RBB
$430M
| $1.48M | ﹤0.01% |
108,700
-36,300
| -25% | -$468K |
2019 Q1
5 quarters
|
|
2348
Hooker Furnishings Corp
HOFT
$133M
| $1.48M | ﹤0.01% |
76,000
-59,965
| -44% | -$959K |
2013 Q2
28 quarters
|
|
2349
Solaris Energy Infrastructure
SEI
$5.03B
| $1.48M | ﹤0.01% |
199,196
-488,679
| -71% | -$3.2M |
2018 Q4
6 quarters
|
|
|
INFI
2350
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.48M | ﹤0.01% |
1,630,638
+245,224
| +18% | +$234K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.